Caprock Group LLC Makes New Investment in iShares Biotechnology ETF $IBB

Caprock Group LLC purchased a new stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) in the 3rd quarter, HoldingsChannel reports. The institutional investor purchased 3,553 shares of the financial services provider’s stock, valued at approximately $491,000.

Several other large investors have also made changes to their positions in IBB. Darwin Wealth Management LLC acquired a new stake in iShares Biotechnology ETF in the second quarter valued at approximately $25,000. Financial Gravity Companies Inc. bought a new position in shares of iShares Biotechnology ETF during the 2nd quarter valued at $29,000. Ashton Thomas Securities LLC bought a new position in iShares Biotechnology ETF during the third quarter valued at about $36,000. Parkside Financial Bank & Trust boosted its stake in shares of iShares Biotechnology ETF by 48.6% during the 3rd quarter. Parkside Financial Bank & Trust now owns 266 shares of the financial services provider’s stock worth $38,000 after acquiring an additional 87 shares in the last quarter. Finally, Princeton Global Asset Management LLC increased its holdings in shares of iShares Biotechnology ETF by 375.0% during the 3rd quarter. Princeton Global Asset Management LLC now owns 380 shares of the financial services provider’s stock valued at $55,000 after acquiring an additional 300 shares during the last quarter. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

NASDAQ:IBB opened at $174.02 on Wednesday. iShares Biotechnology ETF has a 12 month low of $107.43 and a 12 month high of $179.64. The company’s 50 day moving average is $171.87 and its 200-day moving average is $158.14.

iShares Biotechnology ETF Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, December 19th. Shareholders of record on Tuesday, December 16th were given a $0.1831 dividend. The ex-dividend date of this dividend was Tuesday, December 16th. This represents a $0.73 annualized dividend and a yield of 0.4%. This is an increase from iShares Biotechnology ETF’s previous quarterly dividend of $0.08.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.